Search Results 221-230 of 7500 for albumin

  1. Alisertib in Treating Young Patients with Recurrent or Refractory Solid Tumors or Leukemia - Mayo Clinic

    Serum albumin ≥ 2 g/dL; All patients and/or their parents or legal guardians must sign a written informed consent. Exclusion Criteria: Patients who are ...

  2. Projects - Protein Biochemistry and Neuroenzymology Lab: Terrone L. Rosenberry - Mayo Clinic Research

    In one project, Dr. Rosenberry and his laboratory colleagues are studying β-amyloid (Aβ), a component from human brain that may play a role in Alzheimer's ...

  3. A Study to Compare Cabozantinib versus Sunitinib to Treat Metastatic Variant Histology Renal Cell Carcinoma Patients - Mayo Clinic

    Serum albumin ≥ 2.8 g/dl;; Serum creatinine ≤ 2.0 X ULN or calculated creatinine clearance ≥ 30 mL/min (≥ 0.5 mL/sec) using the Cockcroft-Gault equation ...

  4. A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM - Mayo Clinic

    - Albumin ≥ 3 g/dl. - Potassium ≥ lower limit of normal (LLN). - Serum total calcium (correct for serum albumin) or ionized calcium ≥ LLN. - Estimated ...

  5. Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients with Dumping Syndrome - Mayo Clinic

    ... albumin ≥3.5g/dl at baseline; Patients with gastric cancer must have a negative CT or MRI scan (total abdomen); Karnofsky Performance Status ≥ 60 (i.e. ...

  6. SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Chronic Myelomonocytic Leukemia) - Mayo Clinic

    Serum albumin ≥3.2 g/dL (or ≥32 g/L) in the absence of receipt of IV albumin within the previous 72 hours. • Bilirubin ≤1.5 mg/dL. • Aspartate ...

  7. NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study - Mayo Clinic

    History of an allergic reaction to Human Serum Albumin; Has a significant clinical disease or condition; Had previous open thoracotomy procedures; Unable to ...

  8. Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia - Mayo Clinic

    Albumin ≥ 2.5 mg/dL. Willing and able to comply with all aspects of the protocol. Provide written informed consent prior to any study-specific Screening ...

  9. Publications - Ming Yang, M.D. - Mayo Clinic

    99mTc-Macroaggregated Albumin SPECT/CT Perfusion Imaging of Omental Extrahepatic Vascularization. Clin Nucl Med. 2016 Jan; 41: (1)e56-e57. View PubMed ...

  10. Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

    Albumin > 2.5 mg/dL (25 g/L); International normalized ratio (INR) or prothrombin time (PT) =< 1.5 x ULN unless subject is receiving anticoagulant therapy as ...